White Guide and Orange Guide Formatting Project - Pfizer

Orange Guide – Chapter 2: Detailing to HCPs
You may refer general requests from HCPs or other customers to discuss current or future research-
related activities (e.g., clinical trials, IIRs) to the RMRS directly or provide contact information for the
customer to follow-up directly with the RMRS. You may also refer P&T formulary requests from
organized customers to a MOS Colleague who will coordinate any appropriate follow-up with the
RMRS. You may also suggest local or regional thought leaders for the RMRS to consider for specific
Pfizer medical needs; however, the decision to engage with that customer rests solely with the RMRS.
For more information on appropriate interactions with RMRS Colleagues, see the RMRS Guide:
Governance for Field Based Medical Activities (the “Green Guide”).
Communicating Clinical Trial Results
Exhibits and Displays
Q. If I suspect that an HCP would be interested in learning about results from a
clinical trial looking at a new use for one of Pfizer's products, am I allowed to
ask a RMRS Colleague to speak to that physician about the trial results?
A. No. No colleague, including RMRS and MOS Colleagues, can promote the
results of an unapproved or off-label study to an HCP at the request of a
commercial colleague, nor may they encourage the HCP to ask about new offlabel
uses. The only time that a Pfizer Medical Colleague can provide off-label
information to a customer is in response to a specific unsolicited question
seeking such information as set forth in the Green Guide or Purple Guide. Any
unsolicited request for off-label information must be referred to USMI.
Pfizer is often given the opportunity to promote Pfizer products and RC- approved information and
materials to customers by paying for an exhibit or display table at an organization's event. An exhibit or
display opportunity can occur at a variety of venues and programs, but the key principle for you to
remember is that Pfizer is paying solely for the space to promote our products and must not pay more
than fair market value for the display opportunity. Money that we allocate to fund an exhibit or display
at independent educational programs should not be used to fund other aspects of the program (e.g.,
speaker honoraria, rental fees, or food). The location of the display should also be separate and apart
from any independent educational activity.
36
Rev. 09/12
Page 21 of 29